T-cell depletion improves outcome after autologous stem cell transplant in patients with systemic lupus erythematosus (SLE)

[1]  A. Voss,et al.  A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets , 2005, Clinical Rheumatology.

[2]  R. Burt,et al.  Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. , 2002, Arthritis and rheumatism.

[3]  L. Kappos,et al.  Hematopoietic stem cell transplantation for multiple sclerosis , 2002, Journal of Neurology.

[4]  P. Brooks,et al.  A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[5]  T. Koike,et al.  High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future direction. , 2002, Internal medicine.

[6]  R. Burt,et al.  Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure? , 2002, Blood.

[7]  L. Kappos,et al.  Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. , 2002, Journal of neurology.

[8]  J. Pedroza,et al.  PROGNOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS IN THE INTENSIVE CARE UNIT (ICU) , 1998 .

[9]  D. Gladman,et al.  Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. , 1997, The Journal of rheumatology.

[10]  J. Esdaile,et al.  Response to treatment as a predictor of longterm outcome in patients with lupus nephritis. , 1994, The Journal of rheumatology.

[11]  Esdaile Jm.  Prognosis in systemic lupus erythematosus. , 1994 .

[12]  R. Storb,et al.  Allogeneic Bone‐Marrow Transplantation , 1983, Immunological reviews.